An overview video that highlights the importance of the 10 transformative recommendations from the Cancer Moonshot Blue Ribbon Panel. Get more information at http://go.usa.gov/xWtCd.
What is the Cancer Moonshot? During his State of the Union address on January 12, 2016, President Barack Obama announced the establishment of a new Cancer Moonshot to accelerate cancer research. The initiative - led by Vice President Joe Biden - aims to make more therapies available to more patients, while also improving our ability to prevent cancer and detect it at an early stage. What is the Blue Ribbon Panel? To ensure that the Cancer Moonshot's goals and approaches are grounded in the best science, President Obama directed the Moonshot Task Force to consult with external experts, including the presidentially appointed National Cancer Advisory Board (NCAB). A Blue Ribbon Panel of experts was established as a working group of the NCAB to assist the board in providing this advice.
Engage patients to contribute their comprehensive tumor profile data to expand knowledge about what therapies work, in whom, and in which types of cancer. Get more information at http://go.usa.gov/xWtg5.
Reduce cancer risk and cancer health disparities through approaches in development, testing and broad adoption of proven prevention strategies. Get more information at http://go.usa.gov/xWt9T.
Create dynamic 3-D maps of human tumor evolution to document the genetic lesions and cellular interactions of each tumor as it evolves from a precancerous lesion to advanced cancer. Get more information at http://go.usa.gov/xWtN4.
Create a national ecosystem for sharing and analyzing cancer data so that researchers, clinicians and patients will be able to contribute data, which will facilitate efficient data analysis. Get more information at http://go.usa.gov/xWtjV.
Improve our understanding of fusion oncoproteins in pediatric cancer and use new preclinical models to develop inhibitors that target them. Get more information at http://go.usa.gov/xWtKx.
Accelerate the development of guidelines for routine monitoring and management of patient-reported symptoms to minimize debilitating side effects of cancer and its treatment. Get more information at http://go.usa.gov/xWtkP.
Identify therapeutic targets to overcome drug resistance through studies that determine the mechanisms that lead cancer cells to become resistant to previously effective treatments. Get more information at http://go.usa.gov/xWtTA.
Establish a cancer immunotherapy clinical trials network devoted exclusively to discovering and evaluating immunotherapy approaches. Get more information at http://go.usa.gov/xWt2d.
